Insurers Struggle with Soaring GLP-1 Drug Costs, Seek to Wean Patients Off
With list prices of roughly $1,000 a month, public and private payers are struggling to keep up with ballooning demand for GLP-1 weight loss drugs, leading some to restrict coverage or explore 'deprescription' to taper patients off the medication.